Comment on Analysis Flags Fears Over Avastin

Analysis Flags Fears Over Avastin

A soon-to-be-published analysis comparing Roche's cancer medicine Avastin and Novartis's eye drug Lucentis in treating an eye disease could fan health concerns over Avastin's off-label use and thus avert a feared slide in Lucentis sales in the U.S.

 

Comment On This Story

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More News